FDA's Priorities for Priority Review Vouchers

The evolution of the tropical disease voucher program into a full-fledged market depends heavily on how FDA implements the program. It's not just that the agency has to show that the vouchers will actually buy something of value: the agency also has to allow them to behave like a security.